
Analysis of Protagonist Therapeutics Inc (PTGX) options highlights two strategies for investors: selling a $50.00 strike put, which offers an 18.25% annualized return (2.60% premium) if it expires worthless (66% probability) and an effective entry price of $48.70, or implementing a $65.00 strike covered call. The covered call strategy could yield a 21.92% total return if assigned, or a 5.23% annualized return (0.75% premium) if it expires worthless (70% probability), providing income on current holdings. These examples illustrate how options can be leveraged for yield enhancement or strategic equity acquisition.
The provided text outlines two distinct options strategies for Protagonist Therapeutics (PTGX), which is currently trading at $53.64 per share. The first strategy involves selling an out-of-the-money put contract with a $50.00 strike price, generating a premium of $1.30. This approach offers a potential entry point at an effective cost basis of $48.70, representing a 7% discount to the current share price, should the stock be assigned. Alternatively, if the put expires worthless, which has a stated probability of 66%, the seller would realize a 2.60% return on the cash commitment, equivalent to an 18.25% annualized yield. The second strategy is a covered call for existing shareholders, selling a $65.00 strike call for a $0.40 premium. This caps the total return at 21.92% if the stock is called away, but offers a 70% probability of expiring worthless, in which case the investor keeps the premium for a 5.23% annualized yield boost. Notably, the implied volatilities of the put (61%) and call (76%) are elevated compared to the stock's actual trailing twelve-month volatility of 57%, indicating that the options market is pricing in a higher degree of future price movement than has been recently observed.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
Neutral
Sentiment Score
0.00
Ticker Sentiment